109 related articles for article (PubMed ID: 17086870)
21. Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer.
DeRosier LC; Buchsbaum DJ; Oliver PG; Huang ZQ; Sellers JC; Grizzle WE; Wang W; Zhou T; Zinn KR; Long JW; Vickers SM
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5535s-5543s. PubMed ID: 17875786
[TBL] [Abstract][Full Text] [Related]
22. [Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].
Zhao GZ; Tan WL; Zheng SB; Wu YD; Xie Y; Zhu WH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1623-5, 1628. PubMed ID: 17121717
[TBL] [Abstract][Full Text] [Related]
23. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
Serafino A; Zonfrillo M; Andreola F; Psaila R; Mercuri L; Moroni N; Renier D; Campisi M; Secchieri C; Pierimarchi P
Curr Cancer Drug Targets; 2011 Jun; 11(5):572-85. PubMed ID: 21486216
[TBL] [Abstract][Full Text] [Related]
24. [Clinical study of irinotecan therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer].
Nishina T; Hyodo I; Moriwaki T; Kajiwara T; Tsuzuki T; Hirao K; Tubouchi E; Nasu J; Hirasaki S; Masumoto T; Kubo Y; Kurita A
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1361-4. PubMed ID: 15446557
[TBL] [Abstract][Full Text] [Related]
25. Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments.
Pantazis P
Clin Cancer Res; 1995 Nov; 1(11):1235-44. PubMed ID: 9815917
[TBL] [Abstract][Full Text] [Related]
26. [Thermo-chemotherapy using low-dose CPT-11 in a patient with local recurrence of rectal cancer].
Nishida Y; Hamaji M; Miyazaki S; Sakaguchi H; Ishida M; Itoh T; Kuhara A
Gan To Kagaku Ryoho; 1999 Mar; 26(4):549-52. PubMed ID: 10097756
[TBL] [Abstract][Full Text] [Related]
27. A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis.
Pelz JO; Doerfer J; Hohenberger W; Meyer T
BMC Cancer; 2005 May; 5():56. PubMed ID: 15924622
[TBL] [Abstract][Full Text] [Related]
28. Preparation of camptothecin-loaded PCEC microspheres for the treatment of colorectal peritoneal carcinomatosis and tumor growth in mice.
Dai M; Xu X; Song J; Fu S; Gou M; Luo F; Qian Z
Cancer Lett; 2011 Dec; 312(2):189-96. PubMed ID: 21943824
[TBL] [Abstract][Full Text] [Related]
29. [Recent advance in chemotherapy for advanced colorectal cancer].
Aiba K
Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.
Chen TC; Su S; Fry D; Liebes L
Cancer; 2003 May; 97(9 Suppl):2363-73. PubMed ID: 12712458
[TBL] [Abstract][Full Text] [Related]
31. Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: role of drug sequence and dose.
Cao S; Rustum YM
Cancer Res; 2000 Jul; 60(14):3717-21. PubMed ID: 10919639
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity of CPT-11 for gastrointestinal cancer cells cultured on fixed-contact-sensitive plates.
Matsuoka H; Yano K; Seo Y; Saito T; Tomoda H; Takiguchi S; Kono A
Anticancer Drugs; 1995 Jun; 6(3):413-8. PubMed ID: 7670139
[TBL] [Abstract][Full Text] [Related]
33. in vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer.
Inoue Y; Tanaka K; Hiro J; Yoshiyama S; Toiyama Y; Eguchi T; Miki C; Kusunoki M
Int J Oncol; 2006 Feb; 28(2):479-86. PubMed ID: 16391804
[TBL] [Abstract][Full Text] [Related]
34. Impact of hyperthermia on pharmacokinetics of intraperitoneal mitomycin C in rats investigated by microdialysis.
Sørensen O; Andersen AM; Kristian A; Giercksky KE; Flatmark K
J Surg Oncol; 2014 May; 109(6):521-6. PubMed ID: 24347444
[TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of HER1/EGFR tyrosine kinase inhibitor erlotinib, alone and in combination with CPT-11 (irinotecan) in human colorectal cancer xenograft models.
Chen J; Smith M; Kolinsky K; Adames V; Mehta N; Fritzky L; Rashed M; Wheeldon E; Linn M; Higgins B
Cancer Chemother Pharmacol; 2007 Apr; 59(5):651-9. PubMed ID: 16937104
[TBL] [Abstract][Full Text] [Related]
36. Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cells.
Koizumi F; Kanzawa F; Ueda Y; Koh Y; Tsukiyama S; Taguchi F; Tamura T; Saijo N; Nishio K
Int J Cancer; 2004 Jan; 108(3):464-72. PubMed ID: 14648715
[TBL] [Abstract][Full Text] [Related]
37. Prevention of peritoneal carcinomatosis from colon cancer cell seeding using a pirarubicin solution in rats and nude mice.
Favoulet P; Benoit L; Osmak L; Polycarpe E; Esquis P; Duvillard C; Guiu B; Rat P; Favre JP; Chauffert B
World J Surg; 2004 May; 28(5):451-6. PubMed ID: 15085402
[TBL] [Abstract][Full Text] [Related]
38. New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models.
Lehmann K; Rickenbacher A; Jang JH; Oberkofler CE; Vonlanthen R; von Boehmer L; Humar B; Graf R; Gertsch P; Clavien PA
Ann Surg; 2012 Nov; 256(5):730-7; discussion 737-8. PubMed ID: 23095616
[TBL] [Abstract][Full Text] [Related]
39. Camptothecine encapsulated composite drug delivery system for colorectal peritoneal carcinomatosis therapy: biodegradable microsphere in thermosensitive hydrogel.
Liu L; Wu Q; Ma X; Xiong D; Gong C; Qian Z; Zhao X; Wei Y
Colloids Surf B Biointerfaces; 2013 Jun; 106():93-101. PubMed ID: 23434697
[TBL] [Abstract][Full Text] [Related]
40. [Effects of hyperthermic chemotherapy on gastrointestinal cancer cells in vitro].
Sun YM; Fu J; Zhang W; Zheng ZX; Huang CZ; Yuan XH
Ai Zheng; 2006 Aug; 25(8):974-8. PubMed ID: 16965677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
